Apollo Medical (NASDAQ:AMEH) updated its FY 2021 earnings guidance on Tuesday. The company provided EPS guidance of – for the period. The company issued revenue guidance of $690 million-$710 million, compared to the consensus revenue estimate of $708.98 million.
Several analysts have recently issued reports on the company. Zacks Investment Research upgraded Apollo Medical from a hold rating to a buy rating and set a $30.00 target price for the company in a report on Friday, March 12th. TheStreet upgraded Apollo Medical from a c+ rating to a b- rating in a research note on Tuesday, January 5th.
NASDAQ AMEH traded down $0.24 on Tuesday, hitting $30.57. 61,934 shares of the stock were exchanged, compared to its average volume of 79,722. Apollo Medical has a fifty-two week low of $14.11 and a fifty-two week high of $31.13. The company has a 50-day moving average price of $27.35 and a 200-day moving average price of $22.18. The company has a market cap of $1.68 billion, a PE ratio of 33.13, a PEG ratio of 4.29 and a beta of 0.49. The company has a quick ratio of 2.79, a current ratio of 2.79 and a debt-to-equity ratio of 0.99.
Apollo Medical (NASDAQ:AMEH) last issued its earnings results on Tuesday, March 9th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.09. Apollo Medical had a net margin of 5.01% and a return on equity of 16.69%. The firm had revenue of $176.78 million during the quarter. As a group, equities research analysts predict that Apollo Medical will post 0.92 EPS for the current fiscal year.
In related news, major shareholder Physicians Of Californi Allied sold 1,638,045 shares of the business’s stock in a transaction that occurred on Thursday, April 1st. The stock was sold at an average price of $24.50, for a total transaction of $40,132,102.50. Following the completion of the sale, the insider now owns 17,307,214 shares in the company, valued at $424,026,743. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 11.87% of the stock is currently owned by company insiders.
Apollo Medical Company Profile
Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Recommended Story: Bar Chart
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.